Spoke to mgmt and they don’t see a need to do a full CR, rather a mixture of debt and equity. Doesn’t sound like it will be needed within a month either
to me it provides clear sky to get the results of the federal government medicinal cannabis enquiry (early Feb) which should be positive and should further put a rocket up SP. CR after that maybe at higher levels.
CAN 2020 SP discussion, page-89
-
- There are more pages in this discussion • 139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $17.74M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $3.023K | 78.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 308137 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 166529 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| CAN (ASX) Chart |